Markets

Sector Update: Healthcare

Healthcare shares are generally flat in pre-market trade. In earnings news, Coronado Biosciences ( CNDO ) says Q2 net loss was $0.38 per share, wider than the Thomson Reuters mean for a $0.31 loss.

And Curis ( CRIS ) is down 0.25% at $4.01 as it reports a Q2 net loss of $1.3 million, or $0.02 per share as compared to a net loss of $2.9 million or ($0.04) per share on both a basic and fully diluted basis for the same period in 2012. Revenues for Q2 2013 were $5.4 million, as compared to $4.4 million for the same period in 2012. Analyst estimates were not available.

The company currently anticipates that it will end 2013 with cash, cash equivalents and investments of $49 million to $54 million, which includes the $6 million milestone payment that Curis earned in July 2013 related to the conditional approval of Erivedge in the European Union.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

CRIS

Other Topics

Commodities

Latest Markets Videos